96 related articles for article (PubMed ID: 31398660)
1. Generation of two human induced pluripotent stem cell (hiPSC) lines from a long QT syndrome South African founder population.
Mura M; Pisano F; Stefanello M; Ginevrino M; Boni M; Calabrò F; Crotti L; Valente EM; Schwartz PJ; Brink PA; Gnecchi M
Stem Cell Res; 2019 Aug; 39():101510. PubMed ID: 31398660
[TBL] [Abstract][Full Text] [Related]
2. Generation of the human induced pluripotent stem cell (hiPSC) line PSMi007-A from a Long QT Syndrome type 1 patient carrier of two common variants in the NOS1AP gene.
Mura M; Pisano F; Stefanello M; Ginevrino M; Boni M; Calabrò F; Crotti L; Valente EM; Schwartz PJ; Brink PA; Gnecchi M
Stem Cell Res; 2019 Apr; 36():101416. PubMed ID: 30878014
[TBL] [Abstract][Full Text] [Related]
3. NOS1AP is a genetic modifier of the long-QT syndrome.
Crotti L; Monti MC; Insolia R; Peljto A; Goosen A; Brink PA; Greenberg DA; Schwartz PJ; George AL
Circulation; 2009 Oct; 120(17):1657-63. PubMed ID: 19822806
[TBL] [Abstract][Full Text] [Related]
4. NOS1AP polymorphisms reduce NOS1 activity and interact with prolonged repolarization in arrhythmogenesis.
Ronchi C; Bernardi J; Mura M; Stefanello M; Badone B; Rocchetti M; Crotti L; Brink P; Schwartz PJ; Gnecchi M; Zaza A
Cardiovasc Res; 2021 Jan; 117(2):472-483. PubMed ID: 32061134
[TBL] [Abstract][Full Text] [Related]
5. Sex is a moderator of the association between NOS1AP sequence variants and QTc in two long QT syndrome founder populations: a pedigree-based measured genotype association analysis.
Winbo A; Stattin EL; Westin IM; Norberg A; Persson J; Jensen SM; Rydberg A
BMC Med Genet; 2017 Jul; 18(1):74. PubMed ID: 28720088
[TBL] [Abstract][Full Text] [Related]
6. Complex aberrant splicing in the induced pluripotent stem cell-derived cardiomyocytes from a patient with long QT syndrome carrying KCNQ1-A344Aspl mutation.
Wuriyanghai Y; Makiyama T; Sasaki K; Kamakura T; Yamamoto Y; Hayano M; Harita T; Nishiuchi S; Chen J; Kohjitani H; Hirose S; Yokoi F; Gao J; Chonabayashi K; Watanabe K; Ohno S; Yoshida Y; Kimura T; Horie M
Heart Rhythm; 2018 Oct; 15(10):1566-1574. PubMed ID: 29857160
[TBL] [Abstract][Full Text] [Related]
7. Generation of the human induced pluripotent stem cell (hiPSC) line PSMi006-A from a patient affected by an autosomal recessive form of long QT syndrome type 1.
Mura M; Bastaroli F; Corli M; Ginevrino M; Calabrò F; Boni M; Crotti L; Valente EM; Schwartz PJ; Gnecchi M
Stem Cell Res; 2020 Jan; 42():101658. PubMed ID: 31785541
[TBL] [Abstract][Full Text] [Related]
8. Patient-independent human induced pluripotent stem cell model: A new tool for rapid determination of genetic variant pathogenicity in long QT syndrome.
Chavali NV; Kryshtal DO; Parikh SS; Wang L; Glazer AM; Blackwell DJ; Kroncke BM; Shoemaker MB; Knollmann BC
Heart Rhythm; 2019 Nov; 16(11):1686-1695. PubMed ID: 31004778
[TBL] [Abstract][Full Text] [Related]
9. The common long-QT syndrome mutation KCNQ1/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds: toward a mutation-specific risk stratification.
Crotti L; Spazzolini C; Schwartz PJ; Shimizu W; Denjoy I; Schulze-Bahr E; Zaklyazminskaya EV; Swan H; Ackerman MJ; Moss AJ; Wilde AA; Horie M; Brink PA; Insolia R; De Ferrari GM; Crimi G
Circulation; 2007 Nov; 116(21):2366-75. PubMed ID: 17984373
[TBL] [Abstract][Full Text] [Related]
10. Human Induced Pluripotent Stem Cell-Derived Engineered Heart Tissue as a Sensitive Test System for QT Prolongation and Arrhythmic Triggers.
Lemoine MD; Krause T; Koivumäki JT; Prondzynski M; Schulze ML; Girdauskas E; Willems S; Hansen A; Eschenhagen T; Christ T
Circ Arrhythm Electrophysiol; 2018 Jul; 11(7):e006035. PubMed ID: 29925535
[TBL] [Abstract][Full Text] [Related]
11. Generation of eight human induced pluripotent stem cell (iPSC) lines from familial Long QT Syndrome type 1 (LQT1) patients carrying KCNQ1 c.1697C>A mutation (NUIGi005-A, NUIGi005-B, NUIGi005-C, NUIGi006-A, NUIGi006-B, NUIGi006-C, NUIGi007-A, and NUIGi007-B).
Ge N; Liu M; Krawczyk J; McInerney V; Galvin J; Shen S; O'Brien T; Prendiville T
Stem Cell Res; 2019 Aug; 39():101502. PubMed ID: 31415974
[TBL] [Abstract][Full Text] [Related]
12. Generation of the human induced pluripotent stem cell (hiPSC) line PSMi004-A from a carrier of the KCNQ1-R594Q mutation.
Mura M; Lee YK; Pisano F; Ginevrino M; Boni M; Calabrò F; Crotti L; Valente EM; Schwartz PJ; Tse HF; Gnecchi M
Stem Cell Res; 2019 May; 37():101431. PubMed ID: 30974404
[TBL] [Abstract][Full Text] [Related]
13. Functional hyperactivity in long QT syndrome type 1 pluripotent stem cell-derived sympathetic neurons.
Winbo A; Ramanan S; Eugster E; Rydberg A; Jovinge S; Skinner JR; Montgomery JM
Am J Physiol Heart Circ Physiol; 2021 Jul; 321(1):H217-H227. PubMed ID: 34142889
[TBL] [Abstract][Full Text] [Related]
14. Generation of the human induced pluripotent stem cell (hiPSC) line PSMi005-A from a patient carrying the KCNQ1-R190W mutation.
Mura M; Lee YK; Pisano F; Ginevrino M; Boni M; Calabrò F; Crotti L; Valente EM; Schwartz PJ; Tse HF; Gnecchi M
Stem Cell Res; 2019 May; 37():101437. PubMed ID: 31009818
[TBL] [Abstract][Full Text] [Related]
15. Of founder populations, long QT syndrome, and destiny.
Brink PA; Schwartz PJ
Heart Rhythm; 2009 Nov; 6(11 Suppl):S25-33. PubMed ID: 19880070
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic variability and unusual clinical severity of congenital long-QT syndrome in a founder population.
Brink PA; Crotti L; Corfield V; Goosen A; Durrheim G; Hedley P; Heradien M; Geldenhuys G; Vanoli E; Bacchini S; Spazzolini C; Lundquist AL; Roden DM; George AL; Schwartz PJ
Circulation; 2005 Oct; 112(17):2602-10. PubMed ID: 16246960
[TBL] [Abstract][Full Text] [Related]
17. Generation of patient-specific induced pluripotent stem cell lines with Type 2 Long QT Syndrome and the KCNH2 c.379C > T pathogenic variant.
Goual L; Bounasri E; Vincenti M; Amédro P; Desprat R; Bernex F; Lemaitre JM; Pasquié JL; Lacampagne A; Thireau J; Meli AC
Stem Cell Res; 2023 Oct; 72():103192. PubMed ID: 37660555
[TBL] [Abstract][Full Text] [Related]
18. Pathogenic mechanism and gene correction for LQTS-causing double mutations in KCNQ1 using a pluripotent stem cell model.
Wang Z; Wang L; Liu W; Hu D; Gao Y; Ge Q; Liu X; Li L; Wang Y; Wang S; Li C
Stem Cell Res; 2019 Jul; 38():101483. PubMed ID: 31226583
[TBL] [Abstract][Full Text] [Related]
19. Allele-specific ablation rescues electrophysiological abnormalities in a human iPS cell model of long-QT syndrome with a CALM2 mutation.
Yamamoto Y; Makiyama T; Harita T; Sasaki K; Wuriyanghai Y; Hayano M; Nishiuchi S; Kohjitani H; Hirose S; Chen J; Yokoi F; Ishikawa T; Ohno S; Chonabayashi K; Motomura H; Yoshida Y; Horie M; Makita N; Kimura T
Hum Mol Genet; 2017 May; 26(9):1670-1677. PubMed ID: 28335032
[TBL] [Abstract][Full Text] [Related]
20. Tbx20 controls the expression of the KCNH2 gene and of hERG channels.
Caballero R; Utrilla RG; Amorós I; Matamoros M; Pérez-Hernández M; Tinaquero D; Alfayate S; Nieto-Marín P; Guerrero-Serna G; Liu QH; Ramos-Mondragón R; Ponce-Balbuena D; Herron T; Campbell KF; Filgueiras-Rama D; Peinado R; López-Sendón JL; Jalife J; Delpón E; Tamargo J
Proc Natl Acad Sci U S A; 2017 Jan; 114(3):E416-E425. PubMed ID: 28049825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
